Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial

JOURNAL ARTICLE published February 2018 in Leukemia

Authors: H Goldschmidt | H M Lokhorst | E K Mai | B van der Holt | I W Blau | S Zweegman | K C Weisel | E Vellenga | M Pfreundschuh | M J Kersten | C Scheid | S Croockewit | R Raymakers | D Hose | A Potamianou | A Jauch | J Hillengass | M Stevens-Kroef | M S Raab | A Broijl | H W Lindemann | G M J Bos | P Brossart | M van Marwijk Kooy | P Ypma | U Duehrsen | R M Schaafsma | U Bertsch | T Hielscher | Le Jarari | H J Salwender | P Sonneveld